Status:
COMPLETED
TSH Receptor Mutations Among a Consanguineous Community
Lead Sponsor:
HaEmek Medical Center, Israel
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Hypothyroidism
Eligibility:
All Genders
Brief Summary
Resistance to thyrotropin (RTSH) is a condition of impaired responsiveness of the thyroid gland to TSH, characterized by elevated TSH, low or normal thyroid hormone levels, and hypoplastic or normal-s...
Detailed Description
Resistance to thyrotropin (RTSH) is a syndrome involving reduced sensitivity to TSH. It is characterized by elevated TSH, absence of goiter (normal or hypoplastic thyroid gland) and normal to very low...
Eligibility Criteria
Inclusion
- Subjects belonging to extended family of the index case
Exclusion
Key Trial Info
Start Date :
December 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
209 Patients enrolled
Trial Details
Trial ID
NCT00747760
Start Date
December 1 2005
End Date
December 1 2006
Last Update
September 11 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Samuell Refetoff
Chicago, Illinois, United States, 60637-1470
2
Ha'Emek Medical Center
Afula, Israel, 18101